Clinical Trials List
Protocol NumberCETB115G2201
Completed
2020-09-30 - 2025-01-31
Phase II
Not yet recruiting2
ICD-10D46.4
Refractory anemia, unspecified
ICD-10D61.9
Aplastic anemia, unspecified
ICD-9284.9
Aplastic anemia, unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- HSUAN JEN SHIH 無
- 高小雯 無
- Ming-Chung Kao 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
36 participants
